Endoplasmic reticulum stress in melanoma pathogenesis and resistance

Yi Kong1, Jian Jiang1, Yuqiong Huang1

  • 1Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road No.1277, Wuhan, Hubei Province 430022, China.

Insights

Melanoma cells face endoplasmic reticulum (ER) stress, activating the unfolded protein response (UPR). Targeting ER stress and UPR pathways offers new therapeutic strategies for melanoma treatment and overcoming drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Melanoma is an aggressive skin cancer with increasing incidence and limited treatment efficacy.
  • Drug resistance and poor prognosis remain significant clinical challenges in melanoma management.
  • Melanoma's genetic mutations and metabolic state induce endoplasmic reticulum (ER) stress, disrupting cellular protein balance (proteostasis).

Purpose of the Study:

  • To review the role of ER stress and the unfolded protein response (UPR) in melanoma.
  • To explore the interplay between ER stress, UPR, and melanoma pathogenesis and resistance.
  • To discuss therapeutic strategies targeting ER stress and UPR in melanoma.

Main Methods:

  • Literature review of studies on ER stress and UPR in melanoma.
  • Analysis of signaling pathways involved in ER stress and UPR.
  • Examination of the crosstalk between ER stress, UPR, and immune cells in the tumor microenvironment.

Main Results:

  • ER stress activates three UPR branches (IRE1α, PERK, ATF6), influencing melanoma cell fate.
  • ER stress and UPR are implicated in melanoma development and resistance to therapies.
  • Crosstalk exists between ER stress/UPR in melanoma cells and tumor-infiltrating immune cells.

Conclusions:

  • Understanding ER stress and UPR mechanisms is crucial for deciphering melanoma biology.
  • Targeting ER stress and UPR pathways presents a promising therapeutic avenue for melanoma.
  • Further research into ER stress and UPR modulation could improve melanoma patient outcomes.

Related Concept Videos

Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K